2,5-Dimethoxy-4-methylphenylcyclopropylamine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
2,5-Dimethoxy-4-methylphenylcyclopropylamine
DMCPA.png
DMCPA-3d-sticks.png
Names
IUPAC name
2-(2,5-Dimethoxy-4-methylphenyl)cyclopropanamine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
Properties
C12H17NO2
Molar mass 207.273 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references

2,5-Dimethoxy-4-methylphenylcyclopropylamine (DMCPA) is a lesser-known psychedelic drug and a substituted amphetamine. DMCPA was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 15–20 mg and the duration is listed as 4–8 hours.[1] DMCPA produces open-eye visuals, anorexia, and psychedelic dreams. Shulgin gives it a +++ on the Shulgin Rating Scale.

Legality[edit]

United Kingdom[edit]

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]

Pharmacology[edit]

Very little data exists about the pharmacological properties, metabolism, and toxicity of DMCPA.

See also[edit]

References[edit]

  1. ^ DMCPA Entry in PiHKAL
  2. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.